{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T16:44:52Z","timestamp":1697906692451},"reference-count":15,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:00:00Z","timestamp":1146096000000},"content-version":"vor","delay-in-days":7482,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[1985,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Twenty\u2010four patients who were known to develop bronchoconstriction in response to isocapnic hyperventilation (IH) took part in a double\u2010blind, placebo\u2010controlled trial to assess the effects of verapamil (5 mg) and sodium cromoglycate (SCG) 20 mg in the prevention of IH\u2010induced bronchoconstriction. Both drug and placebo were inhaled in dry powder form and responses were assessed by serial measurements of forced expiratory volume in 1 sec (FEV<jats:sub>1<\/jats:sub>).<\/jats:p><jats:p>Sodium cromoglycate was shown to offer significant protection whereas verapamil powder provoked bronchoconstriction in over 40% of patients and these patients appeared to be those with more marked degrees of bronchial reactivity.<\/jats:p>","DOI":"10.1111\/j.1365-2222.1985.tb02306.x","type":"journal-article","created":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T12:53:10Z","timestamp":1146228790000},"page":"531-534","source":"Crossref","is-referenced-by-count":2,"title":["Effects of verapamil and sodium cromoglycate on bronchoconstriction induced by isocapnic hyperventilation"],"prefix":"10.1111","volume":"15","author":[{"given":"P.","family":"RAFFERTY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"FERGUSSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. M.","family":"TWEEDDALE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. A.","family":"BIGGS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. W. B.","family":"GRANT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197910043011406"},{"key":"e_1_2_1_3_2","first-page":"156","article-title":"Inhibition of exercise\u2010induced asthma by a calcium antagonist nifedipine","volume":"123","author":"Cerrina J","year":"1981","journal-title":"Am. Rev. Respir. Dis"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6268.932"},{"key":"e_1_2_1_5_2","first-page":"66","volume-title":"Second International Adalat Symposium","author":"Fleckenstein\u2010Grun G","year":"1976"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.36.8.596"},{"key":"e_1_2_1_7_2","first-page":"307","article-title":"The ventilatory capacity of patients with chronic airways obstruction","volume":"36","author":"Clark TJH","year":"1969","journal-title":"Clin Sci"},{"key":"e_1_2_1_8_2","first-page":"927","article-title":"Sodium cromoglycate induced changes in the dose response curve of inhaled methacholine and histamine in asthmatic children","volume":"119","author":"Woenne R","year":"1979","journal-title":"Am. Rev. Respir. Dis"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90113-6"},{"key":"e_1_2_1_10_2","first-page":"11","article-title":"The effects of cromolyn sodium on the airway response to hyperpnea and cold air in asthma","volume":"122","author":"Breslin FJ","year":"1980","journal-title":"Am. Rev. Respir. Dis"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1982.tb02539.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(83)90071-2"},{"issue":"4","key":"e_1_2_1_13_2","first-page":"42","article-title":"Inhibitors of anaphylaxis in airway smooth muscle by the calcium channel drugs, verapamil and nifedipine","volume":"123","author":"Weiss EB","year":"1981","journal-title":"Am. Rev. Respir. Dis"},{"issue":"4","key":"e_1_2_1_14_2","first-page":"44","article-title":"Inhibition of the release of platelet activating factor and slow\u2010reactive substance from human neutrophils by the calcium antagonist nifedipine","volume":"123","author":"Cerrina J","year":"1981","journal-title":"Am. Rev. Respir. Dis"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(83)90065-9"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1983.tb02578.x"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.1985.tb02306.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.1985.tb02306.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T13:17:25Z","timestamp":1697807845000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.1985.tb02306.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,11]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1985,11]]}},"alternative-id":["10.1111\/j.1365-2222.1985.tb02306.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.1985.tb02306.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,11]]}}}